Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 - a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein-like Receptor 1- on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction.
Van Tassell BW, Wohlford GF, Del Buono MG, Damonte JI, Markley R, Turlington J, Kadariya D, Talasaz A, Ho J, Marawan A, Thomas GK, Austin D, Gineste C, Gelber C, Abbate A. Van Tassell BW, et al. Among authors: kadariya d. J Cardiovasc Pharmacol. 2022 Nov 1;80(5):672-678. doi: 10.1097/FJC.0000000000001331. J Cardiovasc Pharmacol. 2022. PMID: 35881895
Alirocumab in Acute Myocardial Infarction: Results From the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT).
Trankle CR, Wohlford G, Buckley LF, Kadariya D, Ravindra K, Markley R, Park TS, Potere N, Van Tassell BW, Abbate A. Trankle CR, et al. Among authors: kadariya d. J Cardiovasc Pharmacol. 2019 Sep;74(3):266-269. doi: 10.1097/FJC.0000000000000706. J Cardiovasc Pharmacol. 2019. PMID: 31356537 Free PMC article. Clinical Trial.
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.
Abbate A, Trankle CR, Buckley LF, Lipinski MJ, Appleton D, Kadariya D, Canada JM, Carbone S, Roberts CS, Abouzaki N, Melchior R, Christopher S, Turlington J, Mueller G, Garnett J, Thomas C, Markley R, Wohlford GF, Puckett L, Medina de Chazal H, Chiabrando JG, Bressi E, Del Buono MG, Schatz A, Vo C, Dixon DL, Biondi-Zoccai GG, Kontos MC, Van Tassell BW. Abbate A, et al. Among authors: kadariya d. J Am Heart Assoc. 2020 Mar 3;9(5):e014941. doi: 10.1161/JAHA.119.014941. Epub 2020 Mar 3. J Am Heart Assoc. 2020. PMID: 32122219 Free PMC article. Clinical Trial.
Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure.
Wohlford GF, Van Tassell BW, Billingsley HE, Kadariya D, Canada JM, Carbone S, Mihalick VL, Bonaventura A, Vecchié A, Chiabrando JG, Bressi E, Thomas G, Ho AC, Marawan AA, Dell M, Trankle CR, Turlington J, Markley R, Abbate A. Wohlford GF, et al. Among authors: kadariya d. J Cardiovasc Pharmacol. 2020 Oct 24;77(1):49-60. doi: 10.1097/FJC.0000000000000931. J Cardiovasc Pharmacol. 2020. PMID: 33235030 Free PMC article. Clinical Trial.
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials.
Abbate A, Wohlford GF, Del Buono MG, Chiabrando JG, Markley R, Turlington J, Kadariya D, Trankle CR, Biondi-Zoccai G, Lipinski MJ, Van Tassell BW. Abbate A, et al. Among authors: kadariya d. Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):503-510. doi: 10.1093/ehjcvp/pvab075. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34617567 Free PMC article.
Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction.
Del Buono MG, Damonte JI, Trankle CR, Kadariya D, Carbone S, Thomas G, Turlington J, Markley R, Canada JM, Biondi-Zoccai GG, Kontos MC, Van Tassell BW, Abbate A. Del Buono MG, et al. Among authors: kadariya d. Sci Rep. 2022 Jan 24;12(1):1254. doi: 10.1038/s41598-022-05374-w. Sci Rep. 2022. PMID: 35075216 Free PMC article. Clinical Trial.
Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials.
Buckley LF, Carbone S, Trankle CR, Canada JM, Erdle CO, Regan JA, Viscusi MM, Kadariya D, Billingsley H, Arena R, Abbate A, Van Tassell BW. Buckley LF, et al. Among authors: kadariya d. J Cardiovasc Pharmacol. 2018 Jul;72(1):68-70. doi: 10.1097/FJC.0000000000000591. J Cardiovasc Pharmacol. 2018. PMID: 29738374 Free PMC article.
C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction.
van Wezenbeek J, Canada JM, Ravindra K, Carbone S, Trankle CR, Kadariya D, Buckley LF, Del Buono M, Billingsley H, Viscusi M, Wohlford GF, Arena R, Van Tassell B, Abbate A. van Wezenbeek J, et al. Among authors: kadariya d. Front Cardiovasc Med. 2018 Dec 21;5:178. doi: 10.3389/fcvm.2018.00178. eCollection 2018. Front Cardiovasc Med. 2018. PMID: 30619885 Free PMC article.
Noninvasive Hemodynamic Monitoring of Cocaine-Induced Changes in Cardiac Output and Systemic Vascular Resistance in Subjects With Chronic Cocaine Use Disorder.
Van Tassell BW, Westman P, Trankle C, Johns S, Kadariya D, Buckley L, Carbone S, Abbate A, Moeller FG. Van Tassell BW, et al. Among authors: kadariya d. J Cardiovasc Pharmacol. 2019 Dec;74(6):528-534. doi: 10.1097/FJC.0000000000000740. J Cardiovasc Pharmacol. 2019. PMID: 31809403 Free PMC article.
53 results